UPyTher’s mission is to provide custom drug delivery solutions that enable sustained localized administration of therapeutics. With UPyTher’s unique drug-delivery platform physicians and pharmaceutical industry have the means to radically improve the effectiveness of conventional and novel drug therapies in an affordable and patient-friendly manner.

UPyTher develops custom drug delivery solutions for conventional and next generation therapeutics. UPyTher’s lead indication will revolutionize the treatment of peritoneal cancer, which is one of the most deadly cancers and affects hundreds of thousands of patients worldwide. Aggressive hyperthermic intraperitoneal chemotherapy (HIPEC) is considered standard of care, but is also associated with poor therapeutic efficacy because it only allows short exposure to the drug. UPyTher offers a single shot therapy for peritoneal cancer that allows local continuous drug exposure to improve therapeutic efficacy, patient recovery and survival.